Ingredient and material planning
Slippery elm material identity and botanical specification
Private label gummies projects
Develop a gummy brief combining slippery elm, a probiotic blend and xylooligosaccharide prebiotic fiber. Review the botanical material, probiotic specifications and gummy matrix together for a private label project.

Prepare a project brief for quotation. Formula, packaging and commercial terms are agreed for the individual project.
Develop a gummy brief combining slippery elm, a probiotic blend and xylooligosaccharide prebiotic fiber. Review the botanical material, probiotic specifications and gummy matrix together for a private label project. Formulation direction: Ulmus rubra, a probiotic blend and xylooligosaccharides (XOS). Individual cultures, strain identifiers, quantities and the complete gummy base are reviewed for the agreed formulation.
Product directions and reference artwork do not establish a fixed factory formula, certification, raw-material origin, allergen status or destination-market approval.
Develop a gummy brief combining slippery elm, a probiotic blend and xylooligosaccharide prebiotic fiber. Review the botanical material, probiotic specifications and gummy matrix together for a private label project.







Product direction overview
Develop a gummy brief combining slippery elm, a probiotic blend and xylooligosaccharide prebiotic fiber. Review the botanical material, probiotic specifications and gummy matrix together for a private label project. Formulation direction: Ulmus rubra, a probiotic blend and xylooligosaccharides (XOS). Individual cultures, strain identifiers, quantities and the complete gummy base are reviewed for the agreed formulation. Final formulation, quantities, material sources, certifications and market requirements are reviewed for the agreed project.
Share your Slippery Elm, Probiotic and Prebiotic Gummies ingredient brief, intended market, packaging and estimated quantity.
Share your Slippery Elm, Probiotic and Prebiotic Gummies ingredient brief, intended market, packaging and estimated quantity.
OEM/ODM support scope
Bodakang Bio helps buyers structure product discussions before quotation, sample review and order coordination.
Slippery elm material identity and botanical specification
Individual probiotic cultures, strain identifiers and CFU declaration basis
Review bottle and gummy-count planning, protective requirements and project-specific sample scope.
Review product-specific material specifications, analytical requirements, stability and storage information, and labeling for the intended market. Reports and certifications require a separate scope check.
Suitable dosage form
Develop a gummy brief combining slippery elm, a probiotic blend and xylooligosaccharide prebiotic fiber. Review the botanical material, probiotic specifications and gummy matrix together for a private label project.
Private label customization
Final customization depends on confirmed formula, dosage form, package type, quantity and target market requirements.
Packaging options
Packaging can be discussed after product direction, dosage form and quantity range are clearer.
Suitable buyer types
These pages are written for B2B buyers preparing OEM/ODM and private label project discussions.
Project process
The process keeps buyer requirements, formula direction, packaging needs and document discussion organized before production coordination.
01
02
03
04
05
Formula discussion
Bring your specification or describe the product direction you need.
Project quotation
Commercial terms are confirmed for the agreed project scope.
MOQ and quotation are confirmed against the formula, packaging and expected order quantity.
Sample availability, scope, fees and timing are agreed for the project.
Production lead time is reviewed after material and packaging requirements are defined.
Buyer FAQ
Prepare the product and commercial brief before sampling and order confirmation.
The direction combines slippery elm, probiotics and an XOS prebiotic. It is distinct from a broader multi-botanical probiotic gummy and from an XOS capsule.
No strain identifier, viable count or end-of-shelf-life CFU specification is promised. Define the cultures, production and shelf-life measurement basis, storage and supporting information for the proposed project.
No. The image illustrates a possible gummy presentation, not a fixed flavor or fruit ingredient. Agree the complete matrix, color, shape and sensory brief separately.
It is a reference pack count for discussion. Final count, gummy mass, ingredient amounts and packaging are agreed for the project; a daily serving is not inferred.
Share the ingredient specifications, intended market, packaging brief and expected order quantity. MOQ, quotation, sample availability, fees, sample timing and production lead time are reviewed for the individual project rather than taken from an example package.
Agree the product specification, material information, analytical requirements, stability scope and destination-market label requirements. Reports, certificates and approvals must be reviewed for their actual product and process scope; none is implied by the illustration.
Related product directions
Use these pages to compare dosage forms, adjacent product directions and broader private label support options.